calcium channel blocker
Showing 1 - 25 of 4,046
Long-term Use of CCB and Breast Cancer Risk
Active, not recruiting
- Hypertension,Essential
- Breast Cancer
- Calcium channel blocker
- +5 more
-
Bentley, Western Australia, AustraliaCurtin university
Aug 1, 2023
Vasospasm;Peripheral, Burning, Pain Trial (Verapamil, Nicardipine)
Not yet recruiting
- Vasospasm;Peripheral
- +2 more
- (no location specified)
Nov 21, 2022
Angina, Stable Ischemic Heart Disease Trial in United States (Clinician Discretion, Beta blocker, Calcium channel blocker)
Not yet recruiting
- Angina
- Stable Ischemic Heart Disease
- Clinician Discretion
- +2 more
-
Oakland, California
- +4 more
Mar 23, 2023
ive Alzheimer's Medicines- Dihydropyridine Calcium Channel
Active, not recruiting
- Hypertension
- Dihydropyridine calcium channel blocker
- Hydrochlorothiazide
-
Boston, MassachusettsBrigham and Women's Hospital
Mar 1, 2022
Atrial Fibrillation, Diastolic Dysfunction, HFpEF - Heart Failure With Preserved Ejection Fraction Trial in Burlington (As
Recruiting
- Atrial Fibrillation
- +2 more
- As needed pharmacological rate control with beta-blocker (metoprolol tartrate, metoprolol succinate) or calcium channel blocker (diltiazem, verapamil)
-
Burlington, VermontUniversity of Vermont Medical Center
Feb 28, 2023
Atrial Fibrillation Trial in Boston (Beta-blocker strategy, Calcium channel blocker strategy, Physician preference strategy)
Withdrawn
- Atrial Fibrillation
- Beta-blocker strategy
- +2 more
-
Boston, MassachusettsBoston Medical Center MICU
Dec 1, 2021
Hypertension Trial (losartan potassium (+ hydrochlorothiazide [HCTZ] + calcium channel blocker [CCB]), Low Salt Diet)
Completed
- Hypertension
- losartan potassium (+ hydrochlorothiazide [HCTZ] + calcium channel blocker [CCB])
- Low Salt Diet
- (no location specified)
Feb 7, 2022
Therapeutic Drug Use for CKD Patients
Active, not recruiting
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
-
Jinan, Shandong, ChinaXiao Li，MD
Apr 18, 2023
Preterm Labor With Preterm Delivery Trial in Egypt (Potassium Channel Opener, Calcium channel blocker)
Recruiting
- Preterm Labor With Preterm Delivery
- Potassium Channel Opener
- Calcium channel blocker
-
Egypt, Alexandria, EgyptManella Fayez Zaki Beshara
Apr 13, 2021
Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in United States (drug, behavioral, other)
Completed
- Cognitively Normal Older Adults
- +3 more
- Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine)
- +3 more
-
Kansas City, Kansas
- +3 more
Feb 12, 2022
Unexplained Infertility, Polycystic Ovarian Syndrome, Anovulatory Trial in Waltham (Placebo, Nimodipine)
Completed
- Unexplained Infertility
- +2 more
- Placebo
- Nimodipine
-
Waltham, MassachusettsBoston IVF
Aug 10, 2020
Dihydropyridine Calcium Channel Inhibitors on Respiratory Gas
Completed
- Hypoxia
- dihydropyridine calcium channel inhibitors use
-
Caen, Normandie, FranceCaen University Hospital, Department of Pharmacology
Sep 8, 2022
Primary Aldosteronism, Endocrine Hypertension Trial (Cinnarizine, NIFEdipine ER)
Not yet recruiting
- Primary Aldosteronism
- Endocrine Hypertension
- Cinnarizine
- NIFEdipine ER
- (no location specified)
Jan 12, 2023
Raynaud Disease, Systemic Sclerosis, Digital Ulcer Trial in Seoul (Calcium Channel Blockers, Phosphodiesterase Inhibitors,
Terminated
- Raynaud Disease
- +2 more
- Calcium Channel Blockers
- +4 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 8, 2020
Primary Aldosteronism, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral) Trial in Boston (Amlodipine)
Recruiting
- Primary Aldosteronism
- Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
-
Boston, MassachusettsAnand Vaidya
Nov 26, 2021
Early Vascular Adjustments to Prevent Preeclampsia
Completed
- Preeclampsia
- +2 more
- tailored pharmaceutical treatment
-
Maastricht, NetherlandsMaastricht UMC
Mar 10, 2020
Essential Hypertension Trial (Azilsartan Medoxomil Potassium Tablet, Nifedipine Sustained -release Tablets, Levoamlodipine
Not yet recruiting
- Essential Hypertension
- Azilsartan Medoxomil Potassium Tablet
- +2 more
- (no location specified)
Jul 21, 2023
Long QT Syndrome Trial in Rochester (Placebo, Ranolazine)
Completed
- Long QT Syndrome
- Placebo
- Ranolazine
-
Rochester, New YorkUniversity of Rochester
Mar 15, 2022
Coronary Microvascular Dysfunction, Microvascular Angina, Vasospasm, Coronary Trial in Germany, Switzerland (Bisoprolol,
Recruiting
- Coronary Microvascular Dysfunction
- +5 more
- Bisoprolol
- +2 more
-
Bad Nauheim, Germany
- +14 more
Mar 15, 2022
Hypertension, COVID-19 Trial in Galway (Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor)
Suspended
- Hypertension
- COVID-19
- Thiazide or Thiazide-like diuretics
- +3 more
-
Galway, IrelandUniversity Hospital Galway
Jun 26, 2020
Frozen Embryo Transfer Trial in Montpellier, Nîmes (Amlodipine 5mg, Placebo)
Recruiting
- Frozen Embryo Transfer
- Amlodipine 5mg
- Placebo
-
Montpellier, France
- +1 more
Jul 28, 2022
Atrial Fibrillation With Rapid Ventricular Response, Hypotension Trial (Placebo, Calcium)
Not yet recruiting
- Atrial Fibrillation With Rapid Ventricular Response
- Hypotension
- Placebo
- Calcium
- (no location specified)
Jan 11, 2023
Resistant Hypertension Trial in Worldwide (Experimental drug, Placebo)
Recruiting
- Resistant Hypertension
- Experimental drug
- Placebo
-
Guntersville, Alabama
- +28 more
Jan 13, 2023
Pain Trial in Vienna (Room temperature, Cold temperature, Lidocain)
Not yet recruiting
- Pain
- Room temperature
- +6 more
-
Vienna, AustriaMedical University of Vienna
Jul 6, 2023
Hypertension Trial in Beijing, Zoucheng, ShenZhen (Protocol initiate with A, Protocol initiate with C, Protocol initiate with D)
Recruiting
- Hypertension
- Protocol initiate with A
- +2 more
-
Beijing, Henan, China
- +2 more
Apr 14, 2021